qiming
Lv43
800 积分
2023-11-20 加入
-
Characterization of 0839 – A tool compound for pre-clinical mode-of-action studies of amylin analogues such as cagrilintide
2小时前
已关闭
-
A Phase IIb, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Early-stage Parkinson’s disease (PADOVA): Rationale, Design, and Baseline Data
7小时前
待确认
-
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus
14天前
已完结
-
RAMP3 deficiency enhances postmenopausal obesity and metabolic disorders
14天前
已完结
-
RAMP1 and RAMP3 Differentially Control Amylin’s Effects on Food Intake, Glucose and Energy Balance in Male and Female Mice
14天前
已完结
-
Adenosine: A Partial Agonist of the Growth Hormone Secretagogue Receptor
21天前
已完结
-
Design, Biological Characterization, and Discovery of Capromorelin Derivatives as Oral Growth Hormone Secretagogue Receptor Type 1a Agonist for the Treatment of Growth Hormone Deficiency
22天前
已完结
-
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
22天前
已完结
-
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial
22天前
已完结
-
Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial
22天前
已完结